Hiroshi Mikami

5.0k total citations
194 papers, 3.9k citations indexed

About

Hiroshi Mikami is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Hiroshi Mikami has authored 194 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Cardiology and Cardiovascular Medicine, 48 papers in Endocrinology, Diabetes and Metabolism and 30 papers in Surgery. Recurrent topics in Hiroshi Mikami's work include Hormonal Regulation and Hypertension (40 papers), Renin-Angiotensin System Studies (38 papers) and Blood Pressure and Hypertension Studies (17 papers). Hiroshi Mikami is often cited by papers focused on Hormonal Regulation and Hypertension (40 papers), Renin-Angiotensin System Studies (38 papers) and Blood Pressure and Hypertension Studies (17 papers). Hiroshi Mikami collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Mikami's co-authors include Toshio Ogihara, Kazuko Masuo, Jitsuo Higaki, Michael L. Tuck, Masahiro Nagano, Hideki Kawaguchi, Mitsuaki Nakamaru, Koichi Higashimori, Hiromi Rakugi and Ryuichi Morishita and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Hiroshi Mikami

184 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Mikami Japan 34 1.6k 879 750 707 563 194 3.9k
Ferdinando Franzoni Italy 35 1.6k 1.0× 572 0.7× 524 0.7× 976 1.4× 630 1.1× 148 4.3k
KAORU YOSHINAGA Japan 40 1.9k 1.2× 1.7k 1.9× 1.2k 1.5× 811 1.1× 877 1.6× 524 6.8k
León Ferder Argentina 43 1.2k 0.7× 885 1.0× 1.2k 1.6× 1.0k 1.4× 378 0.7× 105 4.8k
P Scheffer Netherlands 38 735 0.5× 877 1.0× 1.0k 1.3× 930 1.3× 498 0.9× 116 4.6k
Jennifer C. Sullivan United States 36 1.3k 0.8× 1.0k 1.2× 797 1.1× 955 1.4× 299 0.5× 121 4.2k
Shigeyuki Saitoh Japan 34 1.1k 0.7× 853 1.0× 913 1.2× 752 1.1× 438 0.8× 134 3.8k
Per M. Humpert Germany 33 765 0.5× 1.0k 1.2× 1.0k 1.4× 849 1.2× 379 0.7× 71 4.8k
Fadi J. Charchar Australia 34 2.2k 1.4× 953 1.1× 1.5k 2.0× 977 1.4× 625 1.1× 117 6.2k
Massimo Fini Italy 40 1.0k 0.6× 1.1k 1.3× 1.2k 1.6× 700 1.0× 300 0.5× 126 5.0k
Ichiro Wakabayashi Japan 29 831 0.5× 983 1.1× 778 1.0× 743 1.1× 405 0.7× 271 3.8k

Countries citing papers authored by Hiroshi Mikami

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Mikami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Mikami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Mikami more than expected).

Fields of papers citing papers by Hiroshi Mikami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Mikami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Mikami. The network helps show where Hiroshi Mikami may publish in the future.

Co-authorship network of co-authors of Hiroshi Mikami

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Mikami. A scholar is included among the top collaborators of Hiroshi Mikami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Mikami. Hiroshi Mikami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanihara, Hidenobu, Tetsuya Yamamoto, Makoto Aihara, et al.. (2023). Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine. Advances in Therapy. 40(8). 3559–3573. 10 indexed citations
2.
Kabayama, Mai, Hiroshi Mikami, & Kei Kamide. (2016). Factors associated with risk for assisted living among community-dwelling older Japanese. Archives of Gerontology and Geriatrics. 65. 63–69. 10 indexed citations
3.
Horie, Shigeo, Shuichi Ito, Hirokazu Okada, et al.. (2014). Japanese guidelines of the management of hematuria 2013. Clinical and Experimental Nephrology. 18(5). 679–689. 23 indexed citations
4.
Takai, Shinro, Masao Akagi, Bruce Crawford, et al.. (2013). Economic Impact of Venous Thromboembolism Following Major Orthopaedic Surgery in Japan. Value in Health Regional Issues. 2(1). 81–86. 5 indexed citations
5.
Mikami, Hiroshi. (2011). Appropriate health care services for the elderly focusing on lifestyle support. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 48(3). 235–238. 1 indexed citations
6.
Sugiura, Katsuaki, et al.. (2009). Gender Differences in Spousal Caregiving in Japan. The Journals of Gerontology Series B. 64B(1). 147–156. 53 indexed citations
7.
Kobayashi, Yôko, Kazuo Hayakawa, Mikiko Ito, et al.. (2006). Linguistic Features of Japanese Twins at 3 or 4 Years of Age Evaluated by Illinois Test of Psycholinguistic Abilities. Twin Research and Human Genetics. 9(2). 272–278. 1 indexed citations
8.
Dosaka‐Akita, Hirotoshi, Koichi Honma, Yoshiaki Saitoh, et al.. (2000). Pneumoconiosis-related Lung Cancers. American Journal of Respiratory and Critical Care Medicine. 162(1). 295–300. 44 indexed citations
9.
Muratani, Hiromi, Yorio Kimura, Koshiro Fukiyama, et al.. (2000). Control of Blood Pressure and Lifestyle-Related Risk Factors in Elderly Japanese Hypertensive Subjects.. Hypertension Research. 23(5). 441–449. 11 indexed citations
10.
Hietanen, Eino, Matti Kataja, Kazuko Masuo, et al.. (1996). Sleep Apnea and Sympathetic Fundion. American Journal of Hypertension. 9(4). 5A–5A.
11.
Ogihara, Toshio, Hiromi Rakugi, Kazuko Masuo, et al.. (1994). Antihypertensive Effects of the Neutral Endopeptidase Inhibitor SCH 42495 in Essential Hypertension. American Journal of Hypertension. 7(11). 943–947. 32 indexed citations
12.
Ogihara, Toshio, Masahiro Nagano, Jitsuo Higaki, et al.. (1993). Antihypertensive efficacy of FK906, a novel human renin inhibitor.. PubMed. 15(3). 539–48. 8 indexed citations
13.
Aoki, Masako, et al.. (1992). A case of facial caulescent malignant melanoma.. Skin Cancer. 7(3). 281–284. 1 indexed citations
14.
Nagano, Masahiro, Jitsuo Higaki, Hiroshi Mikami, et al.. (1991). Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. Journal of Hypertension. 9(7). 595–599. 83 indexed citations
15.
Hoshi, Kenji, et al.. (1991). A case of sebaceous adeno carcinoma in the temporal region.. Skin Cancer. 6(2). 257–259. 2 indexed citations
16.
Morishita, Ryuichi, Jitsuo Higaki, Hideki Okunishi, et al.. (1991). EFFECT OF LONG‐TERM TREATMENT WITH AN ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR ON THE RENIN‐ANGIOTENSIN SYSTEM IN SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 18(10). 685–690. 10 indexed citations
17.
Otsuka, Atsuhiro, et al.. (1989). Changes in plasma renin activity and aldosterone concentration in response to endothelin injection in dogs. European Journal of Endocrinology. 121(3). 361–364. 17 indexed citations
18.
Otsuka, Atsuhiro, et al.. (1989). Effect of ouabain on hemodynamics in acute volume expanded hypertensive dogs. Basic Research in Cardiology. 84(3). 319–325. 1 indexed citations
19.
Abe, Shosaku, et al.. (1985). Reversibility of bronchial atypia on stopping smoking and/or cessation of exposure to chromate dust.. Haigan. 25(1). 13–18. 1 indexed citations
20.
Mikami, Hiroshi, et al.. (1978). The Concentration of Chromium in the Tissues of the Respiratory. Haigan. 18(4). 341–348. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferdinando Franzoni Breakdown of academic impact, for papers by KAORU YOSHINAGA Breakdown of academic impact, for papers by León Ferder Breakdown of academic impact, for papers by P Scheffer Breakdown of academic impact, for papers by Jennifer C. Sullivan Breakdown of academic impact, for papers by Shigeyuki Saitoh Breakdown of academic impact, for papers by Per M. Humpert Breakdown of academic impact, for papers by Fadi J. Charchar Breakdown of academic impact, for papers by Massimo Fini Breakdown of academic impact, for papers by Ichiro Wakabayashi
Rankless by CCL
2026